NanoMicro Technology Awarded '2025 Outstanding Supplier' by Qilu Pharmaceutical

(Source:NanoMicro Technology）

Recently, NanoMicro Technology has been honored with awards for its stable product quality and professional services.Qilu Pharmaceutical "2025 Annual Outstanding Supplier" Award, this recognition is not only an affirmation of the company's core business strength but also a reflection of the fruitful results of the long-term in-depth cooperation between the two parties.

Gaining Customer Recognition

NanoMicro Technology always adheres to the core values of "innovation, precision, customer-first, integrity, and collaboration," deeply cultivating the key track of separation and purification. With high-performance, cost-effective products and customized solutions, it provides stable and reliable supply chain support for industry partners such as Qilu Pharmaceutical, helping to improve production efficiency and optimize product quality.

As a leading enterprise in China's pharmaceutical industry, Qilu Pharmaceutical has been deeply engaged in the field of healthcare, always driving industrial development through technological innovation. The awarding of the "Outstanding Supplier" title is a high recognition of NanoMicro Technology's product strength, service level, and cooperation sincerity, as well as an important testament to the long-term collaboration and coordinated development between the two parties.

Looking Forward to the Future

In the future, NanoMicro Technology will continue to focus on technological innovation and quality upgrading, further deepen collaborative cooperation with partners, and build an industrial ecosystem and promote high-quality development in the industry with better products and more professional services.

About Qilu Pharmaceutical

Qilu Pharmaceutical is committed to maintaining human health as its mission, fulfilling social needs as its responsibility, and relying on advanced science and technology. It is dedicated to the research, development, and production of drugs for common diseases, frequently occurring illnesses, and various other serious diseases that pose significant threats to human health.

Headquartered in Jinan, Shandong Province, the company is a large-scale comprehensive modern pharmaceutical enterprise in China, specializing in the research, production, and sales of formulations and active pharmaceutical ingredients for the treatment of tumors, cardiovascular and cerebrovascular diseases, anti-infection, mental system, nervous system, and ophthalmic diseases.